Russian Move To Limit Medtech Imports Could Harm Domestic Innovation

Import substitution and tendering practices that put non-Russian/EAEU-based medtech manufacturers at a disadvantage were introduced under Russian Resolution 102 in February 2015. Clinica asked executives from IMEDA, Russia’s International Medical Device Manufacturers Association, what effect this will have on market supply, patient care and innovation